{"nct_id":"NCT01377012","title":"Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2011-08-30","start_date_type":"ACTUAL","primary_completion_date":"2015-09-09","primary_completion_date_type":"ACTUAL","completion_date":"2015-09-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}